Eisai Inc. has agreed to withdraw its weight-loss drugs Belviq and Belviq XR (lorcaserin) at the request of the U.S. Food and Drug Administration (FDA). The FDA announced the request on February 13, after a safety clinical trial of found an increased occurrence of cancer in Belviq users. There were several types of cancer found, including … [Read more...]
About US Recall News
Heart Medication Recalled Due to Contamination and Cancer Risk
On July 13, 2018, The U.S. Food and Drug Administration (FDA) announced a voluntary recall of certain medications containing valsartan. Valsartan is the active ingredient in some drugs used to treat high blood pressure and heart failure. Valsartan supplied to the drug manufacturers, by a specific third-party, has been found to be contaminated with … [Read more...]
Tasigna – Atherosclerosis
Tasigna (nilotinib) is a chemotherapy drug originally approved to treat Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Tasigna can have serious and life-threatening side effects, including the development of atherosclerosis. When the drug was approved by the U.S. Food and Drug Administration (FDA) in 2007, it carried … [Read more...]
Neocate Baby Formula Injuries
Neocate baby formula has been linked to low phosphorus levels, bone fractures and rickets in infants. Neocate is amino acid-based formula made for babies and young children with severe food allergies including those who are allergic to cow’s milk, soy and other foods. There are several varieties. Infants and children whose primary source of … [Read more...]
Limbrel Recall
At the request of the U.S. Food and Drug Administration (FDA), Primus Pharmaceuticals, Inc. issued a voluntary recall of Limbrel (flavocoxid), in January 2018. Limbrel use has been associated with liver injury and hypersensitivity pneumonitis, a condition in which the alveoli of the lungs become inflamed. Limbrel is a dietary supplement, … [Read more...]
- 1
- 2
- 3
- …
- 224
- Next Page »
Recent Comments